Intel Stock Slides Amid Broad Chip Selloff, AI Demand Concerns

Intel Corporation (INTC) shares fell 3.5% in pre-open trading Tuesday to $88.45, extending post-earnings weakness as a broader selloff hits the semiconductor industry. The decline is being driven by a confluence of factors, including renewed questions about the sustainability of AI-driven demand, rising competition from China, and investor caution ahead of a key Federal Reserve meeting.

Sector-Wide Pressures Mount

A report from Bloomberg has unsettled investors, suggesting Nvidia is pursuing new AI infrastructure deals potentially worth over $750 billion. This has sparked a debate over whether the AI buildout is a genuine infrastructure supercycle or a form of vendor financing, according to the report. Further concerns over "circular" financing arrangements—where suppliers are also major investors in their own customers—arose from reports that Nvidia may backstop $250 billion in funding for OpenAI.

These anxieties compound pressures that emerged Monday after the blockbuster Shanghai debut of Chinese memory chipmaker ChangXin Memory Technologies (CXMT). The company's shares surged roughly 466%, stoking fears of intensifying competition for established players like Micron and AMD. The selloff dragged the VanEck Semiconductor ETF (SMH) down more than 2% on Monday, with weakness continuing into Tuesday as the tech-heavy Nasdaq fell 0.7% in early trading.

Intel-Specific Headwinds

Ad

Beyond the sector-wide turbulence, Intel faces its own set of challenges that are tempering investor enthusiasm. A key milestone in the company's manufacturing turnaround strategy—the announcement of a major external foundry customer—has yet to materialize. This announcement is highly anticipated by the market as a crucial validation of its strategy.

Wall Street analysts also remain divided on the stock's prospects, even after a recent earnings beat. While some firms have raised their price targets, their overall ratings remain cautious:

• Baird: Raised its price target to $125 but maintained a neutral-equivalent rating.
• Bernstein: Lifted its target to $110, also with a neutral-equivalent rating.
• Morgan Stanley: Holds an equal-weight stance with an $84 price target.

This lack of a uniformly bullish outlook from analysts underscores the market's wait-and-see approach. The cautious sentiment is further amplified as the Federal Reserve begins its two-day policy meeting today, keeping risk appetite subdued across the market.